Creative Biolabs Provides New Solutions for SARS-CoV-2 Drug Evaluation
Sep 4, 2023
New York City, New York Sep 3, 2023 (Issuewire.com) - Creative Biolabs, a prominent biotechnology company, leverages its extensive experience gained from prolonged efforts in combating pandemics to introduce the SARS-CoV-2 drug evaluation platform.
Amidst the global ebb and flow of COVID-19 infections, nations worldwide continue to grapple repeated threats from the SARS-CoV-2 virus. In the unyielding pursuit of effective antiviral interventions against SARS-CoV-2, the urgency to develop precise assessment and testing methodologies for these potential treatments has taken center stage.
At the core of its drug evaluation platform, Creative Biolabs pioneers an array of cutting-edge assays, providing support for the evaluation of potential antiviral therapeutic strategies.
A recent publication in the Frontiers journal has generated significant interest. Drawing from cell-based SARS-CoV-2 spike protein interaction assays, the article delves into the neutralization prowess of recombinant and patient-derived serum antibodies.
Recognizing the capacity of vaccines or drugs in neutralizing viruses as a definitive gauge of their effectiveness in both preventing and treating viral diseases, Creative Biolabs introduces an exceptionally efficient pseudovirus neutralization assay for SARS-CoV-2 within this platform.
By simulating the authentic SARS-CoV-2 virus using a pseudovirus and merging it with the exclusive ACE2-293T cell line, this assay empowers researchers to meticulously evaluate the neutralizing potency of potential drug candidates.
In the realm of appraising the antiviral impact of compounds on SARS-CoV-2-infected cells, Creative Biolabs extends an advanced immunofluorescence-based assay for SARS-CoV-2. This innovative technique facilitates the visualization of virus replication, unraveling the intricate mechanisms by which antiviral medications curtail the virus. Especially pertinent for swiftly replicating viruses like SARS-CoV-2, immunofluorescence-based antiviral testing emerges as an exceptionally dependable and insightful approach.
What's more, given the promising landscape of SARS-CoV-2 proteases as pivotal targets for drug development, Creative Biolabs offers a solution with its protease inhibitor assay for SARS-CoV-2. This assay gauges the inhibitory potential of drugs against the virus's protease, an indispensable enzyme for viral replication. To aid researchers in pinpointing potent drug candidates that stifle virus propagation, Creative Biolabs extends protease detection services, expediting the drug development against COVID-19.
The all-encompassing drug evaluation platform engineered by Creative Biolabs additionally boasts an array of cell lines tailored for COVID-19 research. These include ACE2-enhanced or knockout cell lines, TMPRSS2-enhanced or knockout cell lines. Moreover, the platform integrates multiple reverse genetic systems to investigate the lifecycle, replication, transcription, and pathophysiology of SARS-CoV-2.
Eminent experts at Creative Biolabs express their enthusiasm for the newly launched platform, with one expert asserting, "Our team remains resolute in making a positive impact in the ongoing battle against COVID-19. The SARS-CoV-2 drug evaluation platform showcases these advanced assay methods to expedite the journey towards effective antiviral medications."
To learn more about the evaluation platform and its services, please visit https://sars-cov-2.creative-biolabs.com/.
About Creative Biolabs
Creative Biolabs stands as a leading custom service provider, fortified with extensive experience in anti-SARS-CoV-2 drug discovery and development. The expansive spectrum of services proffered by Creative Biolabs encompasses antibody discovery, CAR-T therapy, drug development, and more, all contributing significantly to advancements within the field of life sciences.
Source :Creative Biolabs
This article was originally published by IssueWire. Read the original article here.
More News
Scientists Warn of Another Unseen Risk From Fire: Ozone
Small particulates sent up by wildfires are a well-documented health hazard. But recent research finds that ground-level ozone is now on the rise, too.
How often do you wash your clothes? As social media is left divided, experts settle the debate once and for all
A huge debate has erupted on X (formerly Twitter) over how often you need to wash your clothes.
Could AI really kill all humans? Scientists say an AI armageddon is unlikely - but warn 'enfeeblement' could cause our demise
Leading AI researchers are now sounding the alarm over the growing threat of 'enfeeblement'.
How AI could usher in a 'new scientific golden age' — if it doesn't kill us all first
AI has remarkable potential to exponentially advance scientific discovery, say scientists. But getting out the word of its scientific benefits of can be challenging when forced to compete with headlines about its significant if not existential threat to humanity.
ShinyHunters Suspect Rey Reportedly Detained in Jordan, Helping FBI Identify Group Members
A suspected member of the ShinyHunters digital extortion group, who goes by the online alias "Rey," has been allegedly detained by authorities in Jordan, Reuters reported, citing three people familiar with the matter. Rey, whose real name is Saif al-Din Khader, is said to have been brought into custody on September 29, 2026, cooperating with the U.S. Federal Bureau of Investigation (FBI) and
China-Aligned TA419 Targets U.S. AI Policy Experts With Microsoft AitM Phishing
A new China-nexus cyber espionage group known as TA419 has been attributed to multiple credential phishing campaigns targeting artificial intelligence (AI) experts working for U.S. think tanks, universities, and legal sector organizations. The campaigns have impersonated prominent economists and AI policymakers, as well as a prominent Anthropic employee, to single out an AI policy expert at a
Trust warns of 'tangible' climate threat to heritage sites
A National Trust manager says recent summers have "brought home" the impact of climate change.
‘Unconstitutional’: Advocacy group condemns BitChat's removal from India App Store on govt order, lists four demands
The Internet Freedom Foundation's (IFF) statement came after Jack Dorsey said Apple removed Bitchat from the India App Store following a takedown demand from the Ministry of Electronics and Information Technology (MeitY).
Queen's University students blast off to US for Nasa robotics competition
The students will head to Florida to compete against university teams from Australia, India and the US.
Trump names intelligence chief Clayton as AI czar, to head task force, WSJ reports
AI-TRUMP-CZAR-CLAYTON:Trump names intelligence chief Clayton as AI czar, to head task force, WSJ reports
Quality over quantity: China’s AI microdrama producers battle viewer fatigue
Two decades after stepping away from the spotlight, iconic actress Joey Wong made an unexpected return to the screen – not through a traditional production, but via artificial intelligence-powered reconstruction. In a two-minute video by NetEase this summer, Wong, one of the most well-known actresses of the 1980s and 90s, had some of her most celebrated roles recreated, including the beautiful ghost in A Chinese Ghost Story and an alluring snake demon in Green Snake. The revival is just the tip...
Astronomers get permission for mini-observatory
The Shropshire Astronomical Society plans to install the dome at Rodington village hall.
Recommended
Why I quit the movement shaping AI
Nobel Prizes 2026: What to Know
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.